Juan Garcia Valero

Juan Garcia Valero

Universitat de Barcelona - Barcelona / Spain
Engineering & Technology / Biomedical Engineering
AD Scientific Index ID: 4689035
University of Barcelona
person_outline Juan Garcia Valero's MOST POPULAR ARTICLES
1-) The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphomaA Esteve-Arenys, JG Valero, A Chamorro-Jorganes, D Gonzalez, ...Oncogene 37 (14), 1830-1844, 2018722018
2-) Bax-derived membrane-active peptides act as potent and direct inducers of apoptosis in cancer cellsJG Valero, L Sancey, J Kucharczak, Y Guillemin, D Gimenez, J Prudent, ...Journal of cell science 124 (4), 556-564, 2011702011
3-) Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaN Giménez, A Martínez-Trillos, A Montraveta, M Lopez-Guerra, L Rosich, ...Haematologica 104 (3), 576, 2019402019
4-) The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphomaJG Valero, A Matas-Céspedes, F Arenas, V Rodriguez, J Carreras, ...Leukemia, 2021502021
5-) Daratumumab displays in vitro and in vivo anti-tumor activity in models of B cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens.A Vidal-Crespo, A Matas-Céspedes, V Rodriguez, C Rossi, JG Valero, ...Haematologica 104 (7), 2019452019